SYNOVUS FINANCIAL CORP - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
SYNOVUS FINANCIAL CORP ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q2 2020$77,000
-39.8%
629
-57.5%
0.00%
-50.0%
Q1 2020$128,000
-23.8%
1,480
-7.7%
0.00%0.0%
Q4 2019$168,000
-4.5%
1,604
+4.5%
0.00%
-33.3%
Q3 2019$176,000
-21.8%
1,535
+17.6%
0.00%0.0%
Q2 2019$225,000
+2.3%
1,3050.0%0.00%
-25.0%
Q1 2019$220,000
+193.3%
1,305
+69.5%
0.00%
+300.0%
Q4 2018$75,000
-40.9%
770
+4.8%
0.00%
-50.0%
Q3 2018$127,000
+122.8%
735
+79.3%
0.00%
+100.0%
Q2 2018$57,0004100.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2020
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders